医学
病毒性肝炎
丙型肝炎
肝炎
行动计划
乙型肝炎
公共卫生
甲肝
病毒学
人类免疫缺陷病毒(HIV)
环境卫生
病理
管理
经济
作者
Giten Khwairakpam,Jessica Hicks,Capucine Pénicaud
标识
DOI:10.1016/s2468-1253(23)00280-7
摘要
In 2022, the Global Fund to Fight AIDS, Tuberculosis and Malaria made a welcome move to enable increased financial support for viral hepatitis. International organisations and patient groups have called on countries to include viral hepatitis prevention and treatment services in their national proposals to the Global Fund, and also called on funders such as the US President's Emergency Plan for AIDS Relief (PEPFAR) to integrate viral hepatitis into their programmes. 1 Hicks J Singh G Penicaud C et al. Financing viral hepatitis: catalyzing action for impact. Lancet Gastroenterol Hepatol. 2023; 8: 606-607 Summary Full Text Full Text PDF Google Scholar Financing viral hepatitis: catalysing action for impactGlobally more than 350 million people are living with viral hepatitis, and 1·1 million people die due to viral hepatitis every year.1 The World Health Assembly committed to eliminating viral hepatitis as a major public health threat by 2030,2,3 but countries are not on track to meet this target. To achieve elimination, a rapid scale-up in prevention, diagnostic, and treatment services in low-income and middle-income countries is required. Full-Text PDF
科研通智能强力驱动
Strongly Powered by AbleSci AI